Toggle navigation
Home
Search
Services
Blog
Contact
About
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A.
Alexion Pharmaceuticals, Inc., Cheshire, CT, United States
Search 17 grants from Scott Rollins
Search grants from Alexion Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Investigating impulsivity and social network changes as novel mechanisms of behavior change for Alcoholics Anonymous' (AA) positive effects
Origin of Knowledge: Conceptual Continuity and Change
Characterization of a novel BRCA2 binding protein, B2BP1
Biopterin & Catecholamines in Aging &Neuro-Degeneration
Impact of Alcoholic Beverage Warning Labels
Recently added grants:
Advanced Microscopy Facility
Animal Models of Disease Core
Porphyromonas gingivalis glycine lipids mediate bone loss through TLR2
Biomolecular Analysis Facility
Leptin and Insulin Signaling in SF1 Neurons and Energy Homeostasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052365-03
Application #
2029136
Study Section
Special Emphasis Panel (ZRG4-HEM-2 (02))
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1996-09-05
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Alexion Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Cheshire
State
CT
Country
United States
Zip Code
06410
Related projects
NIH 1996
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
NIH 1995
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
Comments
Be the first to comment on Scott Rollins's grant